Bill Text: OR SB122 | 2013 | Regular Session | Introduced

---

Bill Title: Relating to evidence-based health care.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Failed) 2013-07-08 - In committee upon adjournment. [SB122 Detail]

Download: Oregon-2013-SB122-Introduced.html

---

     77th OREGON LEGISLATIVE ASSEMBLY--2013 Regular Session

NOTE:  Matter within  { +  braces and plus signs + } in an
amended section is new. Matter within  { -  braces and minus
signs - } is existing law to be omitted. New sections are within
 { +  braces and plus signs + } .

LC 1220

                         Senate Bill 122

Sponsored by Senator SHIELDS; Senator STEINER HAYWARD (Presession
  filed.)

                             SUMMARY

The following summary is not prepared by the sponsors of the
measure and is not a part of the body thereof subject to
consideration by the Legislative Assembly. It is an editor's
brief statement of the essential features of the measure as
introduced.

  Authorizes Director of Department of Consumer and Business
Services to adopt rules prohibiting or limiting coverage by
health benefit plans of items, services or medical technologies
pursuant to guidance by Health Evidence Review Commission.

                        A BILL FOR AN ACT
Relating to evidence-based health care; amending ORS 743.010.
Be It Enacted by the People of the State of Oregon:
  SECTION 1. ORS 743.010 is amended to read:
  743.010. In addition to all other powers of the Director of the
Department of Consumer and Business Services   { - with respect
thereto, the director may issue rules - }  with respect to
 { + the approval or disapproval of + } policy forms and health
benefit plan forms described in ORS 742.005 (6)(a) and (b) { + ,
the director may adopt rules + }:
  (1) Establishing minimum benefit standards;
  (2) Requiring the ratio of benefits to premiums to be not less
than a specified percentage in order to be considered reasonable,
and requiring the periodic filing of data that will demonstrate
the insurer's compliance;   { - and - }
  (3) Establishing requirements intended to discourage
duplication or overlapping of coverage and replacement, without
regard to the advantage to policyholders, of existing policies by
new policies { + ; and
  (4) Prohibiting or limiting coverage of items, services or
medical technologies in accordance with coverage guidance
produced by the Health Evidence Review Commission + }.
                         ----------